EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic

Maria Rosa Loffredo, Lucia Nencioni, Maria Luisa Mangoni, Bruno Casciaro iD

Journal of Peptide Science · 2024-01 · 30 (1)

DOI: 10.1002/psc.3534 ↗

At a glance

Übersichtsarbeit in Journal of Peptide Science, published online on 2023-07-28. Written by Maria Rosa Loffredo and 3 co-authors. Institution: Department of Biochemical Sciences "A. Rossi Fanelli", Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza Univers…. Major MEDLINE topics: COVID-19. Cited 23 times so far (Crossref); 258 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Sapienza University of Rome, EU funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases, Sapienza Università di Roma.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The recent pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has highlighted how urgent and necessary the discovery of new antiviral compounds is for novel therapeutic approaches. Among the various classes of molecules with antiviral activity, antimicrobial peptides (AMPs) of innate immunity are among the most promising ones, mainly due to their different mechanisms of action against viruses and additional biological properties. In this review, the main physicochemical characteristics of AMPs are described, with particular interest toward peptides derived from amphibian skin. Living in aquatic and terrestrial environments, amphibians are one of the richest sources of AMPs with different primary and secondary structures. Besides describing the various antiviral activities of these peptides and the underlying mechanism, this review aims at emphasizing the high potential of these small molecules for the development of new antiviral agents that likely reduce the selection of resistant strains.

Subjects

MeSH terms (MEDLINE)

COVID-19HumansSARS-CoV-2PandemicsAntimicrobial PeptidesPeptidesAntiviral Agents

Author keywords

antimicrobial peptidesantiviral activityinnate immunitysevere acute respiratory syndrome coronavirus 2

Substances

Antimicrobial PeptidesPeptidesAntiviral Agents

Authors and institutions

  • Department of Biochemical Sciences "A. Rossi Fanelli", Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
  • Department of Public Health and Infectious Diseases, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.

ORCID profiles: Bruno Casciaro

Funding

  • Sapienza University of Rome
  • EU funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
  • Sapienza Università di Roma

Cite

APA

Loffredo, M. R., Nencioni, L., Mangoni, M. L., & Casciaro, B. (2024). Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic. Journal of Peptide Science, 30(1). https://doi.org/10.1002/psc.3534

Vancouver

Loffredo MR, Nencioni L, Mangoni ML, Casciaro B. Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic. Journal of Peptide Science. 2024;30(1). doi:10.1002/psc.3534

BibTeX
@article{Loffredo2024,
  author = {Loffredo, Maria Rosa and Nencioni, Lucia and Mangoni, Maria Luisa and Casciaro, Bruno},
  title = {Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic},
  journal = {Journal of Peptide Science},
  year = {2024},
  volume = {30},
  number = {1},
  doi = {10.1002/psc.3534}
}
Start for free →